Insulin resistance is invisible to the panel most adults get every year, because the marker that reveals it first, fasting insulin, is almost never ordered. A standard visit reports glucose, calls it normal and ends there, while the pancreas quietly works harder every year to hold that glucose in place. The compensation succeeds for years before it fails and everything worth knowing about your metabolic future happens during those compensated years. The right labs catch it. The usual labs do not.

This guide walks through the insulin resistance labs that matter, what each one actually tells you and how often the panel should repeat for the numbers to mean anything.

Key takeaways
  • Fasting insulin is the earliest useful marker of insulin resistance and it rises years before glucose or HbA1c move.
  • Insulin and glucose belong on the same draw, because together they show both the compensation and the result it is holding.
  • The triglyceride to HDL ratio, already on a standard panel, is a cheap signature of resistance that most reports ignore.
  • HbA1c is essential and late, so it belongs beside insulin rather than in place of it.
  • ApoB completes the picture, because insulin resistance and atherogenic particles travel together.
  • Trends over 90 days beat snapshots over years, which is why the panel belongs on a fixed cadence.

Why glucose alone is the wrong screening tool

Insulin resistance means your cells respond weakly to insulin, so your body compensates by producing more of it. That compensation is remarkably effective. A person can run two or three times the normal insulin output and still post a fasting glucose of 92, which is exactly what the standard panel reports. The number is true and it is also the last thing to move.

By the time fasting glucose crosses 100 or HbA1c crosses 5.7, the compensation has been slipping for years and the process has been feeding fatty liver, triglycerides, blood pressure and central weight gain the whole time. The CDC estimates that more than one in three American adults has prediabetes and that the large majority do not know it, which is less a statement about awareness than about the screening tool. You cannot find a process with a test that only fires at its endpoint.

The good news is that the process is measurable and reversible while it runs. The Diabetes Prevention Program showed that structured lifestyle intervention producing modest weight loss cut progression to type 2 diabetes by 58 percent, which means the window matters and the window is long. It is only long if somebody looks.

The insulin resistance labs that actually answer the question

The insulin resistance panel and what each marker adds

MarkerWhat it tells youWhy the standard panel misses it
Fasting insulinThe effort your pancreas spends holding glucose downRarely ordered outside specialty settings
Fasting glucoseThe result the compensation is holdingOrdered, but read alone it hides the compensation
HbA1cAverage glucose over roughly three monthsOrdered, but it moves late in the process
Triglycerides and HDLThe lipid signature that tracks resistanceOrdered, but the ratio between them is never calculated
ApoBThe atherogenic particle count riding alongRarely ordered, despite being the better risk marker
Liver panelHepatic fat and early metabolic liver changeOrdered, but connected to insulin only in specialist care

The single most clarifying addition is fasting insulin. It costs a fraction of an advanced panel, it is drawn from the same tube as the glucose you already get and it converts a puzzling normal result into a mechanism you can act on. A fasting glucose of 94 means something completely different with a fasting insulin of 5 than it does with a fasting insulin of 18 and the second version is the one that deserves a plan.

Some clinics compute HOMA-IR, an index built from fasting insulin and glucose that estimates how resistant the tissues have become. The index is useful as a summary and we treat it as one lens rather than an oracle, because the raw markers and their trend carry more information than any single formula.

The ratio sitting unused in your existing results

Triglycerides divided by HDL is the cheapest insulin resistance signal in medicine and it requires no new blood draw at all, because both numbers already appear on every standard lipid panel. In clinical use a ratio above roughly 2 raises the question and values above 3 make it harder to ignore. The ratio tracks the metabolic picture closely because insulin resistance shifts the liver toward producing triglyceride-rich particles while lowering HDL.

We raise this because many adults arrive with years of old lab reports and the answer to whether insulin resistance has been running is often already sitting in them, uncalculated and unmentioned. If your reports show triglycerides of 180 and HDL of 42, that is a ratio above 4 and it has been telling a story through every visit where nobody read it.

GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

Why ApoB belongs in the same draw

Insulin resistance is a cardiovascular risk factor and the connection is visible in the particles. The metabolic state that drives glucose problems also drives the liver to ship more atherogenic lipoprotein particles, which is why ApoB, the count of those particles, tends to climb alongside fasting insulin. Reading the two together turns two separate conversations, a metabolic one and a cholesterol one, into the single conversation they actually are.

That is the whole premise of Cardiometabolic Optimization as we practice it. Weight, blood sugar, lipids, hormones and inflammation are one system and the panel that reads them together is the only version worth running. Our Biomarker Audit includes fasting insulin, HbA1c, the full lipid panel with ApoB and Lp(a), hs-CRP and the complete hormone and thyroid panels, repeated every 90 days.

The one lab to request if you request nothing else

Fasting insulin, drawn beside your next fasting glucose. It explains years of normal glucose results, it costs little and it converts a shrug into a plan.

What the numbers mean in practice

Reading the panel is a pattern exercise rather than a single threshold. Fasting insulin under about 10 uIU/mL is generally comfortable and values above 15 deserve attention, though laboratory ranges vary and the trend matters more than the day's value. HbA1c under 5.7 is normal by definition, 5.7 to 6.4 is prediabetes and 6.5 or above is diabetes. A triglyceride to HDL ratio above 2 is the common flag and above 3 is the louder one.

What makes the pattern actionable is the direction. A fasting insulin of 14 that was 9 two years ago is a different situation than a 14 that has been 14 for a decade and no single report distinguishes them. This is the structural argument for a fixed cadence. Four panels a year show the slope of the line and the slope is what tells you whether the plan is working, which is the difference between managing your health and occasionally witnessing it.

What to do when the pattern shows up

The interventions for insulin resistance are unglamorous and effective. Resistance training two to three times a week is the highest-yield single move, because muscle is the body's largest glucose disposal depot and it responds to load. Protein adequacy follows, since muscle cannot be built without it. Sleep repair comes next, because a few short nights measurably reduce insulin sensitivity and untreated sleep apnea keeps the whole system inflamed. Weight loss of five to ten percent, where it is indicated, restores sensitivity directly.

Medication has a place and it is a labs decision rather than a marketing one. Where the compensation is already deep, metformin and branded GLP-1 therapy both have real evidence and the Diabetes Prevention Program trial metformin as well as lifestyle. Where the picture is mild, ninety days of protocol work and a retest is the honest first move. What the decision should never follow is a platform's margin, which is the specific failure our fee structure exists to remove.

The objection we hear most

My glucose is always fine, why would I test insulin? Because the glucose result is the compensation's success and the compensation has a cost that shows up elsewhere first, in triglycerides, in blood pressure, in visceral fat and in the energy crashes you have been calling normal. A person who tests only glucose learns about insulin resistance in the year it stops compensating, which is the most expensive possible year to learn it.

The second objection is cost, because out-of-pocket lab panels can run into hundreds of dollars per draw and many plans decline fasting insulin. Inside the membership the full panel runs quarterly as part of the flat fee with no separate lab decision to make and the clinician who ordered it reads it with you.

What it costs, stated plainly

The Cardiometabolic Optimization Membership is one flat $299 per month. The first charge at checkout is $598, which covers the first two months together: the clinical intake, the first quarterly Biomarker Audit with the full metabolic, inflammatory, hormone and thyroid panels and the second month of clinical care while your protocol is built. From month three it is $299 per month, month to month, cancel anytime after the initial commitment.

That fee covers the doctor and the labs and it stays deliberately separate from any medicine. Prescriptions, when the labs indicate them, are billed separately by your pharmacy at pharmacy cost with zero markup, no molecule upcharge and no dose-escalation fee. One flat fee for the doctor. Zero markup on the medicine. We make money when you get healthier, not when your dose gets stronger. Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation licensed to practice in all 50 states, working under GoodLife Health's clinical protocols. All labs run through the Beluga Health lab network and additional testing beyond the quarterly cadence is billed at pass-through cost.

For the full framework these labs live inside, read the definitive guide to Cardiometabolic Optimization. For the reverse question, why a normal-weight body can still run insulin resistant, read why you can be prediabetic without being overweight. And for the clinical relationship the results live inside, read Direct Primary Care at GoodLife Health.

FAQ

What labs show insulin resistance? The most informative set is fasting insulin drawn beside fasting glucose, HbA1c, triglycerides read against HDL and ApoB. Fasting insulin is the key addition because it rises years before glucose does and the pair together shows both the compensation and the result it is holding.

Can my glucose be normal and my insulin still high? Yes and it is the most common pattern in early insulin resistance. The body compensates by producing more insulin, so glucose stays inside the range for years while the insulin number climbs. A panel that never measures insulin misses the entire early stage.

What is a good fasting insulin level? Most clinicians consider a fasting insulin under about 10 uIU/mL comfortable and values above 15 suspicious of resistance, though laboratories vary in their ranges. The trend across repeated draws matters more than any single value.

What is the triglyceride to HDL ratio? It divides triglycerides by HDL cholesterol and in clinical use a ratio above roughly 2 is a common flag for insulin resistance, with values above 3 considered more strongly predictive. It is not a diagnosis on its own, but it is one of the cheapest signatures of the metabolic picture.

Does HbA1c catch insulin resistance? Late. HbA1c reflects average blood sugar over roughly three months and it stays normal for years while insulin compensation runs. It is an essential marker of where the process has landed and a poor marker of where it started.

How often should insulin resistance labs be repeated? When the picture is being managed actively, every 90 days gives a real trend and a real feedback loop on the interventions. For stable low-risk adults, an annual panel with insulin included is reasonable.

Can insulin resistance be reversed? In many people yes. Weight loss of five to ten percent, resistance training, protein adequacy and sleep repair measurably restore insulin sensitivity and structured lifestyle change cut progression to diabetes by 58 percent in the Diabetes Prevention Program.

Related guides

References

  1. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin (Diabetes Prevention Program, NEJM). 2002. pubmed.ncbi.nlm.nih.gov/11832527/
  2. CDC: Prevent Type 2 Diabetes (Prediabetes overview). 2024. www.cdc.gov/diabetes/prevention-type-2/prediabetes-prevention.html